Efficacy of suplatast tosilate for treatment of atopic dermatitis poorly controlled by other anti-allergic drugs

Yumi Matsumura; Yoshiki Miyachi; Yoshinari Matsumoto; Shun Kitaba; Ichiro Katayama; Akiko Kishioka; Fukumi Furukawa; Yasuo Kubota; Gen Nakanishi; Keiji Iwatsuki; Sakae Kaneko; Eishin Morita; Kunio Izu; Yoshiki Tokura; Shuji Fukagawa; Masutaka Furue; Motoi Takenaka; Shinichi Sato; Kazumoto Katagiri

Efficacy of suplatast tosilate for treatment of atopic dermatitis poorly controlled by other anti-allergic drugs

Yumi Matsumura, Yoshiki Miyachi, Yoshinari Matsumoto, Shun Kitaba, Ichiro Katayama, Akiko Kishioka, Fukumi Furukawa, Yasuo Kubota, Gen Nakanishi, Keiji Iwatsuki, Sakae Kaneko, Eishin Morita, Kunio Izu, Yoshiki Tokura, Shuji Fukagawa, Masutaka Furue, Motoi Takenaka, Shinichi Sato, Kazumoto Katagiri

Graduate School of Medicine Dentistry and Pharmaceutical Sciences

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

The Th2 cytokine inhibitor, suplatast tosilate 300mg/day was administered to 163 patients with atopic dermatitis who had been poorly controlled by other anti-allergic drugs. The usefulness of suplatast tosilate was evaluated witfi respect to skin symptom score and parameters such as IgE, eosinophil and basophil counts, and LDH. After 4 weeks of treatment, the skin symptom score, eosinophil counts and LDH were significantly decreased, whereas other parameters remained unchanged.

Original language	English
Pages (from-to)	1-7
Number of pages	7
Journal	Skin Research
Volume	6
Issue number	SUPPL. 8
Publication status	Published - Mar 2007

Keywords

Atopic dermatitis
Skin symptom score
Suplatast tosilate

ASJC Scopus subject areas

Dermatology
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Matsumura, Y., Miyachi, Y., Matsumoto, Y., Kitaba, S., Katayama, I., Kishioka, A., Furukawa, F., Kubota, Y., Nakanishi, G., Iwatsuki, K., Kaneko, S., Morita, E., Izu, K., Tokura, Y., Fukagawa, S., Furue, M., Takenaka, M., Sato, S., & Katagiri, K. (2007). Efficacy of suplatast tosilate for treatment of atopic dermatitis poorly controlled by other anti-allergic drugs. Skin Research, 6(SUPPL. 8), 1-7.

Matsumura, Y, Miyachi, Y, Matsumoto, Y, Kitaba, S, Katayama, I, Kishioka, A, Furukawa, F, Kubota, Y, Nakanishi, G, Iwatsuki, K, Kaneko, S, Morita, E, Izu, K, Tokura, Y, Fukagawa, S, Furue, M, Takenaka, M, Sato, S & Katagiri, K 2007, 'Efficacy of suplatast tosilate for treatment of atopic dermatitis poorly controlled by other anti-allergic drugs', Skin Research, vol. 6, no. SUPPL. 8, pp. 1-7.

@article{3259e7ffbfae4d15b9ff0c69a3c0c4a5,

title = "Efficacy of suplatast tosilate for treatment of atopic dermatitis poorly controlled by other anti-allergic drugs",

abstract = "The Th2 cytokine inhibitor, suplatast tosilate 300mg/day was administered to 163 patients with atopic dermatitis who had been poorly controlled by other anti-allergic drugs. The usefulness of suplatast tosilate was evaluated witfi respect to skin symptom score and parameters such as IgE, eosinophil and basophil counts, and LDH. After 4 weeks of treatment, the skin symptom score, eosinophil counts and LDH were significantly decreased, whereas other parameters remained unchanged.",

keywords = "Atopic dermatitis, Skin symptom score, Suplatast tosilate",

author = "Yumi Matsumura and Yoshiki Miyachi and Yoshinari Matsumoto and Shun Kitaba and Ichiro Katayama and Akiko Kishioka and Fukumi Furukawa and Yasuo Kubota and Gen Nakanishi and Keiji Iwatsuki and Sakae Kaneko and Eishin Morita and Kunio Izu and Yoshiki Tokura and Shuji Fukagawa and Masutaka Furue and Motoi Takenaka and Shinichi Sato and Kazumoto Katagiri",

year = "2007",

month = mar,

language = "English",

volume = "6",

pages = "1--7",

journal = "Skin Research",

issn = "0018-1390",

publisher = "Osaka University",

number = "SUPPL. 8",

}

TY - JOUR

T1 - Efficacy of suplatast tosilate for treatment of atopic dermatitis poorly controlled by other anti-allergic drugs

AU - Matsumura, Yumi

AU - Miyachi, Yoshiki

AU - Matsumoto, Yoshinari

AU - Kitaba, Shun

AU - Katayama, Ichiro

AU - Kishioka, Akiko

AU - Furukawa, Fukumi

AU - Kubota, Yasuo

AU - Nakanishi, Gen

AU - Iwatsuki, Keiji

AU - Kaneko, Sakae

AU - Morita, Eishin

AU - Izu, Kunio

AU - Tokura, Yoshiki

AU - Fukagawa, Shuji

AU - Furue, Masutaka

AU - Takenaka, Motoi

AU - Sato, Shinichi

AU - Katagiri, Kazumoto

PY - 2007/3

Y1 - 2007/3

N2 - The Th2 cytokine inhibitor, suplatast tosilate 300mg/day was administered to 163 patients with atopic dermatitis who had been poorly controlled by other anti-allergic drugs. The usefulness of suplatast tosilate was evaluated witfi respect to skin symptom score and parameters such as IgE, eosinophil and basophil counts, and LDH. After 4 weeks of treatment, the skin symptom score, eosinophil counts and LDH were significantly decreased, whereas other parameters remained unchanged.

AB - The Th2 cytokine inhibitor, suplatast tosilate 300mg/day was administered to 163 patients with atopic dermatitis who had been poorly controlled by other anti-allergic drugs. The usefulness of suplatast tosilate was evaluated witfi respect to skin symptom score and parameters such as IgE, eosinophil and basophil counts, and LDH. After 4 weeks of treatment, the skin symptom score, eosinophil counts and LDH were significantly decreased, whereas other parameters remained unchanged.

KW - Atopic dermatitis

KW - Skin symptom score

KW - Suplatast tosilate

UR - http://www.scopus.com/inward/record.url?scp=34249113506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249113506&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:34249113506

SN - 0018-1390

VL - 6

SP - 1

EP - 7

JO - Skin Research

JF - Skin Research

IS - SUPPL. 8

ER -

Efficacy of suplatast tosilate for treatment of atopic dermatitis poorly controlled by other anti-allergic drugs

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this